Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium
- PMID: 9144422
- DOI: 10.1006/bbrc.1997.6433
Prostaglandin F2alpha receptor (FP receptor) agonists are potent adipose differentiation inhibitors for primary culture of adipocyte precursors in defined medium
Abstract
Prostaglandin F2alpha inhibits adipose differentiation of primary culture of adipocyte precursors and of the adipogenic cell line 1246 in defined medium. In the present paper, we investigated the effect of FP receptor agonists cloprostenol and fluprostenol on the differentiation of newborn rat adipocyte precursors in primary culture. The results show that cloprostenol and fluprostenol are very potent inhibitors of adipose differentiation. Dose response studies indicate that both agonists are more potent than PGF2alpha in inhibiting adipocyte precursors differentiation. 50% inhibition of adipose differentiation was observed at a concentration of 3 x 10(-12) M for cloprostenol and 3 to 10 x 10(-11) M for fluprostenol respectively whereas the PGF2alpha concentration required to elicit the same effect was 10(-8) M. In contrast compounds structurally related to PGE2 such as 17-phenyl trinor PGE2 had no effect on adipose differentiation except when added at a 10,000-fold higher concentration.
Similar articles
-
Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.Invest Ophthalmol Vis Sci. 1999 Nov;40(12):3047-53. Invest Ophthalmol Vis Sci. 1999. PMID: 10549672
-
Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells.Differentiation. 1996 Jul;60(4):203-10. doi: 10.1046/j.1432-0436.1996.6040203.x. Differentiation. 1996. PMID: 8765050
-
Endothelin antagonism: effects of FP receptor agonists prostaglandin F2alpha and fluprostenol on trabecular meshwork contractility.Invest Ophthalmol Vis Sci. 2006 Mar;47(3):938-45. doi: 10.1167/iovs.05-0527. Invest Ophthalmol Vis Sci. 2006. PMID: 16505027
-
Aldose reductases influence prostaglandin F2α levels and adipocyte differentiation in male mouse and human species.Endocrinology. 2015 May;156(5):1671-84. doi: 10.1210/en.2014-1750. Epub 2015 Mar 2. Endocrinology. 2015. PMID: 25730106
-
[Prostaglandin and cell differentiation].Tanpakushitsu Kakusan Koso. 1992 May;37(6):937-47. Tanpakushitsu Kakusan Koso. 1992. PMID: 1620879 Review. Japanese. No abstract available.
Cited by
-
Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost.Jpn J Ophthalmol. 2013 Mar;57(2):179-84. doi: 10.1007/s10384-012-0219-3. Epub 2012 Dec 13. Jpn J Ophthalmol. 2013. PMID: 23233196
-
The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting.Front Oncol. 2022 Jan 19;11:791696. doi: 10.3389/fonc.2021.791696. eCollection 2021. Front Oncol. 2022. PMID: 35127497 Free PMC article. Review.
-
ROCK inhibitors modulate the physical properties and adipogenesis of 3D spheroids of human orbital fibroblasts in different manners.FASEB Bioadv. 2021 Jul 26;3(10):866-872. doi: 10.1096/fba.2021-00037. eCollection 2021 Oct. FASEB Bioadv. 2021. PMID: 34632320 Free PMC article.
-
Changes to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprost.Jpn J Ophthalmol. 2011 Jan;55(1):22-7. doi: 10.1007/s10384-010-0904-z. Epub 2011 Feb 18. Jpn J Ophthalmol. 2011. PMID: 21331688
-
ROCK inhibitors enhance the production of large lipid-enriched 3D organoids of 3T3-L1 cells.Sci Rep. 2021 Mar 9;11(1):5479. doi: 10.1038/s41598-021-84955-7. Sci Rep. 2021. PMID: 33750898 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources